Simultaneous Mapping of Vasculature, Hypoxia, and Proliferation Using Dynamic Susceptibility Contrast MRI,


Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
10 2021
Historique:
received: 12 05 2020
accepted: 14 01 2021
pubmed: 22 5 2021
medline: 6 1 2022
entrez: 21 5 2021
Statut: ppublish

Résumé

Conventional MRI plays a key role in the management of patients with high-grade glioma, but multiparametric MRI and PET tracers could provide further information to better characterize tumor metabolism and heterogeneity by identifying regions having a high risk of recurrence. In this study, we focused on proliferation, hypervascularization, and hypoxia, all factors considered indicative of poor prognosis. They were assessed by measuring uptake of

Identifiants

pubmed: 34016725
pii: jnumed.120.249524
doi: 10.2967/jnumed.120.249524
pmc: PMC8724903
doi:

Substances chimiques

fluoromisonidazole 082285VIDF
Misonidazole 8FE7LTN8XE

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1349-1356

Informations de copyright

© 2021 by the Society of Nuclear Medicine and Molecular Imaging.

Références

Med Image Anal. 2018 Feb;44:177-195
pubmed: 29268169
Cancer Cell. 2010 Jan 19;17(1):98-110
pubmed: 20129251
Clin Cancer Res. 2016 Oct 15;22(20):5079-5086
pubmed: 27185374
J Neurol Sci. 2003 Dec 15;216(1):1-10
pubmed: 14607296
J Nucl Med. 2005 Dec;46(12):1948-58
pubmed: 16330557
Nat Commun. 2014 Jun 19;5:4196
pubmed: 24943270
Cancer Res. 2009 May 15;69(10):4502-9
pubmed: 19366800
Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2404-2412
pubmed: 30032322
N Engl J Med. 2014 Feb 20;370(8):709-22
pubmed: 24552318
Front Surg. 2019 Apr 12;6:21
pubmed: 31032260
Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):240-248
pubmed: 26338178
Ann Nucl Med. 2017 Aug;31(7):495-505
pubmed: 28612247
Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1476-1485
pubmed: 32025750
J Neurooncol. 2009 Feb;91(3):337-51
pubmed: 19009235
Eur J Nucl Med Mol Imaging. 2011 Mar;38(3):441-50
pubmed: 21072512
Radiother Oncol. 2011 Jan;98(1):109-16
pubmed: 21056487
Radiology. 2016 May;279(2):542-52
pubmed: 26579564
Nucl Med Commun. 2019 Oct;40(10):1066-1071
pubmed: 31469809
J Nucl Med. 2017 Oct;58(10):1574-1579
pubmed: 28596159
IEEE Trans Med Imaging. 2009 Jun;28(6):881-93
pubmed: 19150782
Strahlenther Onkol. 2015 Mar;191(3):217-24
pubmed: 25245468
World Neurosurg. 2017 Jul;103:538-549
pubmed: 28427971
Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):301-8
pubmed: 20116934
Front Med (Lausanne). 2019 Jun 12;6:117
pubmed: 31249831
Neuroimage Clin. 2015 May 29;8:448-54
pubmed: 26106569
Neuro Oncol. 2013 Jan;15(1):41-56
pubmed: 23115160
Eur J Nucl Med Mol Imaging. 2014 May;41(5):915-24
pubmed: 24346414
Adv Radiat Oncol. 2019 Sep 07;5(1):53-61
pubmed: 32051890
Clin Cancer Res. 2008 May 1;14(9):2623-30
pubmed: 18451225
Lancet Oncol. 2009 May;10(5):459-66
pubmed: 19269895
Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1147-55
pubmed: 20207495
J Nucl Med. 2012 Jul;53(7):1135-45
pubmed: 22689925
Neurosurgery. 2019 Oct 1;85(4):524-534
pubmed: 30239840
J Neuroradiol. 2019 Nov;46(6):359-366
pubmed: 31229576
Med Phys. 2017 Jun;44(6):e1-e42
pubmed: 28120467
Neuro Oncol. 2020 Aug 17;22(8):1073-1113
pubmed: 32328653
Curr Oncol. 2010 Nov;17(6):52-8
pubmed: 21151410
Int J Radiat Oncol Biol Phys. 2000 Jun 1;47(3):551-60
pubmed: 10837935
Bioengineering (Basel). 2018 Nov 28;5(4):
pubmed: 30487391
Sci Rep. 2017 Aug 31;7(1):10210
pubmed: 28860608
Transl Oncol. 2010 Jun 01;3(3):160-9
pubmed: 20563257
AJNR Am J Neuroradiol. 2006 Apr;27(4):859-67
pubmed: 16611779
Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1383-1392
pubmed: 28315948
Cancer Res. 2011 Dec 15;71(24):7366-75
pubmed: 21900399
J Biomed Biotechnol. 2012;2012:205818
pubmed: 22577290
Clin Cancer Res. 2008 Apr 1;14(7):2049-55
pubmed: 18381944
Strahlenther Onkol. 2012 Apr;188(4):334-9
pubmed: 22349712
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Front Oncol. 2020 Apr 24;10:494
pubmed: 32391260

Auteurs

Solène Collet (S)

Normandie University, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, GIP Cyceron, Caen, France.
Radiophysics Department, Centre François Baclesse, Caen, France.

Jean-Sébastien Guillamo (JS)

Normandie University, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, GIP Cyceron, Caen, France.
Department of Neurology, CHU de Caen, Caen, France.
Department of Neurology, CHU de Nimes, Nimes, France.

David Hassanein Berro (DH)

Normandie University, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, GIP Cyceron, Caen, France.
Department of Neurosurgery, CHU de Caen, Caen, France.

Ararat Chakhoyan (A)

Normandie University, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, GIP Cyceron, Caen, France.

Jean-Marc Constans (JM)

Normandie University, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, GIP Cyceron, Caen, France.
Department of Neuroradiology, CHU de Caen, Caen, France.

Emmanuèle Lechapt-Zalcman (E)

Normandie University, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, GIP Cyceron, Caen, France.
Department of Pathology, CHU de Caen, Caen, France.
Department of Neuropathology, GHU Paris Psychiatry and Neuroscience, Paris, France.

Jean-Michel Derlon (JM)

Normandie University, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, GIP Cyceron, Caen, France.

Mathieu Hatt (M)

LaTIM, INSERM, UMR 1101, University of Brest, Brest, France; and.

Dimitris Visvikis (D)

LaTIM, INSERM, UMR 1101, University of Brest, Brest, France; and.

Stéphane Guillouet (S)

Normandie University, UNICAEN, CEA, CNRS, ISTCT/LDM-TEP Group, GIP Cyceron, Caen, France.

Cécile Perrio (C)

Normandie University, UNICAEN, CEA, CNRS, ISTCT/LDM-TEP Group, GIP Cyceron, Caen, France.

Myriam Bernaudin (M)

Normandie University, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, GIP Cyceron, Caen, France.

Samuel Valable (S)

Normandie University, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, GIP Cyceron, Caen, France; samuel.valable@cnrs.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH